Table 2.
Sedation Characteristics of Study Population
| Variables | Control Group (n = 87) | LF Group (n = 83) | HF Group (n = 83) | P Value |
|---|---|---|---|---|
| Duration of sedation (min) | 40.6 ± 17.8 | 40.2 ± 16.2 | 43.2 ± 24.1 | 0.879 |
| Procedures | 0.923 | |||
| Urodynamic study | 42 (48.8) | 48 (57.8) | 43 (51.8) | 0.453 |
| EGD, colonoscopy | 27 (31.4) | 23 (27.7) | 25 (30.1) | 0.888 |
| MRI | 8 (9.2) | 5 (6.0) | 7 (8.4) | 0.728 |
| Ureteral stent removal | 7 (8.0) | 5 (6.0) | 5 (6.0) | 0.830 |
| Ear procedures | 1 (1.1) | 2 (2.4) | 1 (1.2) | 0.761 |
| Other procedures | 2 (2.3) | 0 | 2 (2.4) | 0.370 |
| Medications used during sedation | 0.840 | |||
| Propofol (IV) | 82 (94.3) | 76 (91.6) | 76 (91.6) | 0.743 |
| Midazolam (IV) | 54 (62.1) | 57 (68.7) | 57 (68.7) | 0.572 |
| Dexmedetomidine (IV) | 22 (25.3) | 14 (16.9) | 18 (21.7) | 0.406 |
| Ketamine (IV) | 4 (4.6) | 6 (7.2) | 7 (8.4) | 0.592 |
Data are presented as mean ± SD and n (%).
EGD, esophagogastroduodenoscopy; HF, high flow; IV, intravenous; LF, low flow; MRI, magnetic resonance imaging.